Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06985602) titled 'Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ' on May 15.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Jiangsu Cancer Institute & Hospital
Condition:
Gastroesophageal Adenocarcinoma
Gastric Adenocarcinoma
Intervention:
Combination Product: Arm 1: Adebrelimab Combined with Chemoradiotherapy Followed by Surgery
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: May 16, 2025
Target Sample Size: 30
Countries of Recruitment:
China
To know more, vi...